Agent- 86
Your guess on this is as good as mine because I really don’t know.
All I can offer is a couple of observations.
Firstly, as I think I’ve said before, if NNZ-2591 is successful in Phase 2 PMD, I think it unlikely that Neuren will be running a Phase 3 trial in PMD or any other indication. My feeling is that, whether we like it or not, it will be Acadia running the show.
That said, I believe that Neuren will continue to work towards making NNZ-2591 a Phase 3-ready asset by completing all the necessary manufacturing requirements (very important step) and meeting with the FDA (and possibly EMA) in a post-Phase 2 meeting to ascertain what the FDA’s pivotal trial requirements are. With respect to trial design, I think that any potential acquirer would prefer to control that.
The clinical trials website suggests that there has been just one Phase 3 trial commenced in PMD, which is still in progress – and that’s a randomized, double-blind placebo-controlled 12 week treatment trial in 7-18 yr olds with PMD and ASD, using a pre-existing drug (lithium). There appears to be just one recruitment site in Paris, and they are aiming to enrol just 22 patients and expect that to take 2 years.
Other current Phase 2 trials in PMD are small (in a couple of cases, just 6 participants) and recruiting at just one or two sites.
However, I’d expect any Phase 3 trial of NNZ-2591 in PMD to be considerably larger than the current Phase 2, where all 20 participants are receiving the drug.
- Forums
- ASX - By Stock
- NEU
- Phelan-McDermid Syndrome
Phelan-McDermid Syndrome, page-72
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.14 |
Change
0.785(5.47%) |
Mkt cap ! $1.927B |
Open | High | Low | Value | Volume |
$14.35 | $15.18 | $14.35 | $4.643M | 311.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 565 | $15.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.14 | 511 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 398 | 15.120 |
4 | 567 | 15.110 |
6 | 776 | 15.100 |
9 | 1178 | 15.090 |
5 | 507 | 15.080 |
Price($) | Vol. | No. |
---|---|---|
15.140 | 390 | 8 |
15.150 | 417 | 4 |
15.160 | 893 | 6 |
15.170 | 830 | 7 |
15.180 | 539 | 4 |
Last trade - 14.44pm 27/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |